文献速递乳房整形与再造创面修复

腹横肌平面阻滞与腹部游离皮瓣乳房再造:术后阿片类药物用量是否真正减少?

Transversus Abdominis Plane Block and Free Flap Abdominal Tissue Breast Reconstruction: Is There a True Reduction in Postoperative Narcotic Use?
PubMed 文献 · Ann Plast Surg · 2017-01-01

该回顾性研究纳入2013—2015年接受腹部供区游离皮瓣乳房再造的患者,比较放置与未放置TAP阻滞导管各40例匹配队列。结果显示两组术后疼痛评分、住院期间每日及总阿片类药物用量、止吐药使用均无统计学显著差异;TAP导管使用安全,未出现相关并发症。

要点

  • 持续TAP阻滞给药安全,未发生导管相关并发症。
  • TAP阻滞未减少住院期间阿片类药物用量或术后疼痛评分。
  • 单侧即刻再造、BMI大于30 kg/m、供区闭合未置补片者中可见供区镇痛改善趋势,但未达统计学显著。

核心结论

  • 持续经TAP阻滞输注局麻药看似安全,但未减少腹部游离皮瓣乳房再造患者的阿片类药物需求或术后疼痛评分。

研究设计与样本

  • 回顾性分析2013—2015年2年间所有自体显微外科乳房再造患者,仅纳入腹部供区者。
  • TAP阻滞组40例与匹配的无TAP阻滞对照组40例进行比较。
  • 主要终点包括患者报告的疼痛评分、住院期间每日及总阿片类药物用量、止吐药使用及并发症。

主要发现

  • 两组术后疼痛评分无统计学显著差异。
  • 两组住院期间每日或总阿片类药物用量无统计学显著差异。
  • 两组止吐药使用无统计学显著差异。
  • 使用TAP导管未出现相关并发症。
  • 线性回归分析显示单侧即刻再造、BMI大于30 kg/m、供区闭合未置腹部补片者中供区镇痛有改善趋势,但无统计学显著性。

临床怎么用

  • TAP阻滞导管可用于腹部供区术后镇痛且安全性可接受,但不应预期其减少阿片类药物用量或降低疼痛评分。
  • 对单侧即刻再造、BMI大于30 kg/m或供区未置补片者,可个体化考虑TAP阻滞,但证据仅为趋势性。

局限性

  • 回顾性研究设计。
  • 样本量为每组40例,较小。
  • 仅纳入腹部供区患者,结论外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The use of the transversus abdominis plane (TAP) block is increasing in abdominally based autologous tissue breast reconstruction as a method to provide postoperative donor site analgesia. The purpose of this study was to evaluate the efficacy of the TAP block in the immediate postoperative period. METHODS: A retrospective analysis of all patients who underwent autologous microsurgical breast reconstruction over a 2-year period (2013-2015) was conducted. Only patients with an abdominal donor site were included. Patients were grouped based on the presence or absence of TAP blocks. Primary endpoints included patient-reported pain score, daily and total narcotic use during the hospitalization, antiemetic use, as well as complications. RESULTS: We identified 40 patients that had undergone abdominal-based free flap breast reconstruction and TAP block catheter placement for postoperative analgesia that met inclusion criteria. This group was then compared with a matched cohort of 40 patients without TAP blocks. There were no complications associated with using the TAP catheters. There was no statistically significant difference in postoperative pain scores, daily or total narcotic use during the hospitalization, or antiemetic use between the 2 groups. Although not statistically significant, linear regression analysis identified trends of improved donor site analgesia in select groups, such as unilateral immediate reconstructions, body mass index greater than 30 kg/m, and those without abdominal mesh placed at the time of donor site closure in the TAP block group. CONCLUSIONS: Constant delivery of local anesthetic through the TAP block appears to be safe; however, it did not reduce narcotic requirements or postoperative pain scores in patients undergoing abdominal-based free flap breast reconstruction.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Hunter C, Shakir A, Momeni A, et al. Transversus Abdominis Plane Block and Free Flap Abdominal Tissue Breast Reconstruction: Is There a True Reduction in Postoperative Narcotic Use? Ann Plast Surg. 2017. PMID: 28118232. doi:10.1097/SAP.0000000000000873

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。